Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
18/11/2025 13:19
CytoMed Therapeutics Ltd F98.F: CYTOMED THERAPEUTICS COMPLETES ACQUISITION OF T CELL TECHNOLOGY FROM UK TO TREAT CANCERS IN CHINA AND INDIA Source text: ID:nGNX43w0JH Further company coverage: F98.F
Recent news on CytoMed Therapeutics
See all newsBrief: Cytomed Therapeutics Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: CytoMed Therapeutics To Start Dose Level 2 In Angelica Trial Q3 2025
Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million